t(3;14)(p14;q32) Results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma
β Scribed by James A. L. Fenton; Ed Schuuring; Sharon L. Barrans; Alison H. Banham; Sara J. Rollinson; Gareth J. Morgan; Andrew S. Jack; J. Han. J. M. van Krieken; Philip M Kluin
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 253 KB
- Volume
- 45
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Strong expression of Forkhead boxβP1 (FOXP1), a wingedβhelix transcription factor, has been identified as an independent prognostic factor in diffuse large Bβcell lymphoma (DLBCL). However, possible mechanisms of deregulation of this gene, on 3p14.1, have yet to be elucidated. We have identified a breakpoint at the IGA1 gene in the immunoglobulin heavy chain (IGH) locus at 14q32 that was juxtaposed to the FOXP1 gene locus in a gastric DLBCL that showed strong expression of FOXP1. This may be one possible mechanism of deregulating FOXP1 expression by placing it under the control of IGH enhancers. Β© 2005 WileyβLiss, Inc.
π SIMILAR VOLUMES
The novel human pre-B cell line OZ was established from a patient with an aggressive form of non-Hodgkin's lymphoma. Karyotypic analysis of both the primary tumour and OZ cells revealed several marker chromosomes, including the t(14;18)(q32;q21) translocation, which involves the Bcl-2 gene, and alte
## Abstract __ZAC/PLAGL1__ is a ubiquitously expressed, imprinted tumor suppressor gene located on 6q24, a chromosomal region that is frequently deleted in diffuse large Bβcell lymphoma (DLBCL). Like p53, ZAC regulates cell cycle arrest and apoptosis concomitantly, and loss of expression is implica
The LAZ3(BCL6) gene on chromosome band 3q27 is nonrandomly disrupted in B-cell non-Hodgkin lymphoma (B-NHL) by chromosomal translocations clustered within a 3.3-kb MTC (major translocation cluster) located between the two first noncoding exons. These translocations generally result in the expression